PHS 398 Cover Page Supplement Instructions

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

G.210 - PHS 398 Cover Page Supplement Form
The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location.

The PHS 398 Cover Page Supplement Form is used for all grant
applications except fellowships. This form collects information
on human subjects, vertebrate animals, program income, human
embryonic stem cells, inventions and patents, and changes of
investigator/change of institution.

View larger image

Quick Links
1. Vertebrate Animals Section
2. Program Income Section
3. Human Embryonic Stem Cell Section
4. Human Fetal Tissue Section.
5. Inventions and Patents Section (for Renewal applications)
6. Change of Investigator/Change of Institution Section

1. Vertebrate Animals Section
Are vertebrate animals euthanized?
You must answer this question if you answered “Yes” to the question “Are Vertebrate Animals Used?”
on the G.220 – R&R Other Project Information Form.
Check "Yes" or "No" to indicate whether vertebrate animals in the project are euthanized.

Form Screenshots

G.- 53

Additional Instructions for Multi-project:
Overall Component: If vertebrate animals will be euthanized in any Component, then you must
answer “Yes” to the “Are vertebrate animals euthanized?” question.
If “Yes” to euthanasia: Is method consistent with American Veterinary Medical Association (AVMA)
guidelines?
You must answer this question if you answered “Yes” to the “Are vertebrate animals euthanized?”
question above. Check “Yes” or “No” to indicate whether the method of euthanasia is consistent with
the AVMA Guidelines for the Euthanasia of Animals.
For more information: See AVMA Guidelines for the Euthanasia of Animals.
If “No” to AVMA guidelines, describe method and provide scientific justification:
If you answered “No” to the “Is method consistent with AVMA guidelines?” question, you must
describe (in 1000 characters or fewer) the method of euthanasia and provide a scientific justification
for its use. This justification will be reviewed by Office of Laboratory Animal Welfare (OLAW).
If you answered “Yes” to the “Is method consistent with AVMA guidelines” question, skip this
question.

2. Program Income Section
Is program income anticipated during the periods for which the grant support is requested?
This field is required.
If program income is anticipated during the periods for which grant support is requested, check
“Yes,” and complete the rest of the “Program Income” section.
If no program income is anticipated, check “No” and skip the rest of the “Program Income” section.
Additional Instructions for Training:
Check “No” for the “Is program income anticipated during the periods for which the grant support is
requested?” question.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

Additional Instructions for Multi-project:
Overall Component: If you anticipate program income on any component, then answer "Yes." Skip
the other fields, as any information provided in them will be discarded. Instead of program income
information being provided in the Overall Component, a system-generated summary of all program
income information that you provide in Other Components will be included in the summaries section
of the assembled application image.
Other Component: If you anticipate program income on any component, then answer "Yes." Provide
the budget period, anticipated amount, and source information.
Budget Period:
Enter the budget periods for which program income is anticipated. If the application is funded, the
Notice of Grant Award will provide specific instructions regarding the use of such income.
Anticipated Amount ($):
Enter the amount of anticipated program income for each budget period listed.
Source(s):
Enter the source of anticipated program income for each budget period listed.

3. Human Embryonic Stem Cells Section
Use the following instructions to complete the fields in this section.
For additional guidance, see the NIH Grants Policy Statement, Section 4.1.13: Human Stem Cell
Research.
Does the proposed project involve human embryonic stem cells?
This field is required.
If the proposed project involves human embryonic stem cells (hESC), check “Yes” and complete the
rest of the “Human Embryonic Stem Cells” section.
•

Use of the cell lines must be in accordance with the NIH Guidelines for Human Stem Cell
Research.

If the proposed project does not involve hESC, check “No” and skip the rest of the “Human
Embryonic Stem Cells” section.
Additional Instructions for Training:
Check “Yes” if training plans include or potentially will include involvement of trainees in projects that
include hESC. Note that trainees may only conduct research with hESC lines that are approved for use
in NIH-funded research; these cell lines are listed on the NIH hESC Registry. Use of the cell lines must
be in accordance with the NIH Guidelines for Human Stem Cell Research.

Form Screenshots

G.- 55

Additional Instructions for Multi-project:
Overall Component: If human embryonic stem cells are used in any Component, then you must
answer “Yes.”
Specific stem cell line cannot be referenced at this time. One from the registry will be used.
If you will use hESC but a specific line from the NIH hESC Registry cannot be chosen at the time of
application submission, check this box.
If you cannot specify which cell lines will be used at the time of application submission, specific cell
line information will be required as Just-in-Time information prior to award.
Additional Instructions for Research:
If you cannot choose an appropriate cell line from the registry at this time, provide a justification in
the G.400 - PHS 398 Research Plan Form, Research Strategy attachment.

Additional Instructions for Career Development:
If you cannot choose an appropriate cell line from the registry at this time, provide a justification in
the G.410 - PHS 398 Career Development Award Supplemental Form, Research Strategy attachment.

Additional Instructions for Training:
When individual project hESC line information is requested as Just-in-time (JIT), the NIH will require
information regarding project title, mentor, and specific cell line(s) from the registry (NIH hESC
Registry) for each trainee utilizing human embryonic stem cells. Trainees may not participate in hESC
related research until this information has been provided.

Additional Instructions for Multi-project:
Overall and Other Components: If you cannot choose an appropriate cell line from the registry at
this time, provide a justification in the G.400 - PHS 398 Research Plan Form, Research Strategy
attachment.

Additional Instructions for SBIR/STTR:
If you cannot choose an appropriate cell line from the registry at this time, provide a justification in
the G.400 - PHS 398 Research Plan Form, Research Strategy attachment.
Cell Line(s):
List the 4-digit registration number of the specific cell line(s) from the NIH hESC Registry (e.g. 0123).
Up to 200 lines can be added.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

Additional Instructions for Multi-project:
Overall Component: Skip the "Cell Line(s)" field, as any information provided here will be discarded.
Instead of cell line information being provided in the Overall Component, a system-generated
summary of all cell line information that you provide in Other Components will be included in the
summaries section of the assembled application image.
Other Component: Provide any cell line information relevant to the work being done in that
component.
For more information:
See NIH’s Stem Cell Information page for additional information on stem cells, Federal policy statements,
and guidelines on federally funded stem cell research.

4. Human Fetal Tissue Section

The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location.

Does the proposed project involve human fetal tissue from elective abortions?
This field is required.
If the proposed project involves the use of human fetal tissue obtained from elective abortions (HFT),
check “Yes” and complete the rest of the “Human Fetal Tissue” section.
If the proposed project does not involve the use of human fetal tissue obtained from elective
abortions (HFT), check “No” and skip the rest of the “Human Fetal Tissue” section.
Additional Instructions for Multi-project:
Overall Component: If the use of human fetal tissue obtained from elective abortions (HFT) are
proposed in any Component, then you must answer "Yes."
If the answer is "yes" then provide the HFT Compliance Assurance:
If the proposed project involves the use of human fetal tissue obtained from elective abortions (HFT),
the applicant must provide a letter, signed by the PD/PI, assuring the HFT donating organization or
clinic adheres to the requirements of the informed consent process and documenting that HFT was
not obtained or acquired for valuable consideration. The PDF-formatted letter must be named
‘HFTComplianceAssurance.pdf’.
If the answer is “yes” then provide the HFT Sample IRB Consent Form
If the proposed project involves the use of human fetal tissue obtained from elective abortions (HFT),
provide a blank sample of the IRB-approved consent form. The PDF-formatted form must be a blank
sample and named ‘HFTSampleIRBConsentForm.pdf’.
o The informed consent for use of HFT from elective abortions requires language that acknowledges
informed consent for donation of HFT was obtained by someone other than the person who
obtained the informed consent for abortion, that informed consent for donation of HFT occurred
after the informed consent for abortion was obtained will not affect the method of abortion, and that
no enticements, benefits, or financial incentives were used at any level of the process to incentivize

Form Screenshots

G.- 57

abortion or the donation of HFT. The form must be signed by both the woman and the person who
obtains the informed consent.
For further information on HFT policy refer to the NIH Grants Policy Statement, Section 2.3.7.11
Human Fetal Tissue from Elective Abortions, Section 4.1.14 Human Fetal Tissue Research and Section
4.1.14.2 Human Fetal Tissue from Elective Abortions.

5. Inventions and Patents Section (for Renewal applications)
Who must complete the “Invention and Patents” section:
Complete the "Inventions and Patents" section only if you are submitting a renewal application or a
resubmission of a renewal application.
Inventions and Patents:
If no inventions were conceived or reduced to practice during the course of work under this project,
check “No” and skip the remainder of the “Inventions and Patents” section.
If any inventions were conceived or first actually reduced to practice during the previous period of
support, check “Yes.”
NIH recipient organizations must promptly report inventions to the Division of Extramural Inventions
and Technology Resources (DEITR) Branch of the Office of Policy for Extramural Research
Administration (OPERA), OER, NIH, 6705 Rockledge Drive, Bethesda, MD 20892-2750, (301) 4351986. You must report inventions in compliance with regulations at 37 CFR 401.14, which are
described at Interagency Edison (iEdison). The grantee is required to submit reports electronically
using iEdison. See the NIH Grants Policy Statement, Section 8.4.1.6: Invention Reporting.
Additional Instructions for Career Development:
Skip the “Inventions and Patents” section, as it is not applicable.

Additional Instructions for Training:
Skip the “Inventions and Patents” section, as it is not applicable.
Previously Reported:
If you answered “Yes” to the “Inventions and Patents” question, indicate whether this information has
been reported previously to the NIH or PHS agency or to the applicant organization official
responsible for patent matters.

6. Change of Investigator/Change of Institution Section
Change of Project Director/Principal Investigator:
Check this box if your application reflects a change in project director/principal investigator (PD/PI)
from that indicated on your previous application or award. Note that this box not applicable to a new
application, nor is a change in PD/PI permitted for revision applications.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

For a multiple PD/PI application, check this box if this application represents a change in the contact
PI.
If you check the box, fill in the rest of the “Change of PD/PI” section with the information for the
former PD/PI according to the instructions below.
Additional Instructions for Career Development:
Skip the “Change of Project Director/Principal Investigator” section, as changes in PD/PI are not
allowed for career development awards.

Additional Instructions for Fellowship:
Skip the “Change of Project Director/Principal Investigator” section, as changes in PD/PI are not
allowed for fellowship awards.
Prefix:
Enter or select the prefix, if applicable, for the former PD/PI.
First Name:
Enter the first (given) name of the former PD/PI.
Middle Name:
Enter the middle name of the former PD/PI.
Last Name:
Enter the last (family) name of the former PD/PI.
Suffix:
Enter or select the suffix, if applicable, for the former PD/PI.
Change of Grantee Institution:

Check this box if your application reflects a change in grantee institution from that indicated on
your previous application or award. This question is not applicable to new applications.

Name of Former Institution:

Enter the name of the former institution if this application reflects a change in grantee
institution.

Form Screenshots

G.- 59